POTENT ANTITUMOR EFFICACY OF EX VIVO EXPANDED AND CRYOPRESERVED HUMAN NATURAL KILLER CELLS AGAINST ORTHOTOPIC PANCREATIC CANCER

被引：0
|
作者：
Park, G. [1 ]
Yang, B. [1 ]
Kim, E. [1 ]
Kim, H. [1 ]
Kim, Y. [1 ]
Cho, S. [1 ]
Hwang, Y. [1 ]
Min, B. [1 ]
机构：
[1] GCLabcell, Yongin, Gyeonggi Do, South Korea
来源：
CYTOTHERAPY | 2019年 / 21卷 / 05期
关键词：
D O I：
10.1016/j.jcyt.2019.03.361
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
91
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [31] Characterization and ex vivo expansion of human placenta-derived natural killer cells for cancer immunotherapy
    Kang, Lin
    Voskinarian-Berse, Vanessa
    Law, Eric
    Reddin, Tiffany
    Bhatia, Mohit
    Hariri, Alexandra
    Ning, Yuhong
    Dong, David
    Maguire, Timothy
    Yarmush, Martin
    Hofgartner, Wolfgang
    Abbot, Stewart
    Zhang, Xiaokui
    Hariri, Robert
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [32] Ex vivo purification and characterization of human invariant natural killer T cells
    Sharma, Ashish Arunkumar
    Chew, Leon
    Ladd, Mihoko
    Jen, Roger
    Lavoie, Pascal M.
    JOURNAL OF IMMUNOLOGICAL METHODS, 2011, 373 (1-2) : 1 - 7
  • [33] Ex vivo expanded human Vγ9Vδ2+γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro
    Liu, ZY
    Guo, BL
    Gehrs, BC
    Nan, L
    Lopez, RD
    JOURNAL OF UROLOGY, 2005, 173 (05): : 1552 - 1556
  • [34] Ex vivo expanded telomerase-specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma
    Hassanin, H.
    Serba, S.
    Schmidt, J.
    Maerten, A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 158 (01): : 125 - 132
  • [35] Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma
    Kim, Hwan Mook
    Lim, Jaeseung
    Yoon, Yeo Dae
    Ahn, Ji Mi
    Kang, Jong Soon
    Lee, Kiho
    Park, Song-Kyu
    Jeong, Yu Jin
    Kim, Jin Mi
    Han, Gyoonhee
    Yang, Kyu-Hwan
    Kim, Yeon Jin
    Kim, Youngsoo
    Han, Sang-Bae
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (13) : 1793 - 1801
  • [36] Carfilzomib combined with ex vivo-expanded patient autologous natural killer cells for myeloma immunotherapy
    Chang, S. K.
    Hou, J.
    Chen, G. G.
    Yu, D. D.
    Wu, H. Q.
    Xie, Y. S.
    Hu, L. N.
    Gao, L.
    Xiao, W. Q.
    Kong, Y. Y.
    Tao, Y.
    Shi, J. M.
    NEOPLASMA, 2018, 65 (05) : 720 - 729
  • [37] An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
    Lieberman, Nicole A. P.
    DeGolier, Kole
    Haberthur, Kristen
    Chinn, Harrison
    Moyes, Kara W.
    Bouchlaka, Myriam N.
    Walker, Kirsti L.
    Capitini, Christian M.
    crane, Courtney A.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [38] NICOTINAMIDE REJUVENATES EX-VIVO EXPANDED NATURAL KILLER CELLS AND ENHANCES THEIR TUMOR KILLING CAPACITY
    Pato, Aviad
    Hailu, Astar
    Brickman, Nurit
    Yackoubov, Dima
    Cichocki, Frank
    Peled, Amnon
    Simantov, Ronit
    Lodie, Tracey
    Rifman, Julia
    Geffen, Yona
    Berhani-Zipori, Orit
    Edri, Avishay
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A172 - A172
  • [39] Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer
    Chung, Moon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (09) : 939 - 946
  • [40] Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer
    Moon Jae Chung
    Jeong Youp Park
    Seungmin Bang
    Seung Woo Park
    Si Young Song
    Cancer Immunology, Immunotherapy, 2014, 63 : 939 - 946
12345